Leaders
The companies at the top of the measures every stock page draws, recomputed each night from SEC filings. Names under $2B are left out.
A negative cash conversion cycle: customers pay before the suppliers have to be paid, so growth funds itself.
- 2AZOAutoZonepays suppliers in 327 days, collects in 13314 days
- 3APPAppLovinpays suppliers in 410 days, collects in 121289 days
- 4UNHUnitedHealth Grouppays suppliers in 274 days, collects in 19232 days
- 5CRWVCoreWeave, Inc.pays suppliers in 408 days, collects in 225182 days
- 6YUMYum! Brandspays suppliers in 211 days, collects in 37173 days
- 7OMCOmnicom Grouppays suppliers in 477 days, collects in 304173 days
- 8ADSKAutodeskpays suppliers in 237 days, collects in 73164 days
- 9COTYCoty Inc.pays suppliers in 333 days, collects in 33160 days
- 10BCRXBioCryst Pharmaceuticals, Inc.pays suppliers in 303 days, collects in 45155 days
After-tax operating profit on every dollar of debt and equity in the business, cash included; the clearest single sign of a moat.
Cash spent buying back shares minus the shares handed out as pay: only what is left actually returns money to owners.
- 2NVDANVIDIA Corporation$40.1B bought back, $6.4B issued as pay, FY2026$33.7B
- 3JPMJPMorgan Chase$31.6B bought back, $3.6B issued as pay, FY2025$28.0B
- 4GOOGLAlphabet Inc.$45.7B bought back, $25.0B issued as pay, FY2025$20.8B
- 5BACBank of America$21.4B bought back, $4.0B issued as pay, FY2025$17.4B
- 6VVisa Inc.$18.3B bought back, $897M issued as pay, FY2025$17.4B
- 7MAMastercard$11.7B bought back, $597M issued as pay, FY2025$11.1B
- 8MSFTMicrosoft Corporation$22.3B bought back, $12.4B issued as pay, FY2026$9.9B
- 9HCAHCA Healthcare$10.1B bought back, $401M issued as pay, FY2025$9.7B
- 10ADBEAdobe Inc.$11.3B bought back, $1.9B issued as pay, FY2025$9.3B
Stock-based compensation as a share of revenue: a real cost that adjusted earnings add back and owners pay in dilution.
- 2MRNAModerna$483M in FY202524.9%
- 3ZSZscaler, Inc.$822M in FY202624.5%
- 4TEAMAtlassian Corporation$1.6B in FY202624.4%
- 5CRWDCrowdStrike$1.1B in FY202622.8%
- 6DDOGDatadog$751M in FY202521.9%
- 7NETCloudflare, Inc.$451M in FY202520.8%
- 8ALABAstera Labs, Inc.$160M in FY202518.8%
- 9OKTAOkta, Inc.$544M in FY202618.6%
- 10WDAYWorkday, Inc.$1.6B in FY202617.0%
Research and development as a share of revenue: how much of every dollar goes back into what comes next.
- 2DDOGDatadog$1.5B in FY202545.2%
- 3SNOWSnowflake Inc.$2.0B in FY202642.0%
- 4REGNRegeneron Pharmaceuticals$5.9B in FY202540.8%
- 5ONCBeOne Medicines AG$2.1B in FY202540.2%
- 6ALABAstera Labs, Inc.$304M in FY202535.7%
- 7SNPSSynopsys, Inc.$2.5B in FY202535.1%
- 8VRTXVertex Pharmaceuticals$3.9B in FY202532.6%
- 9CRWDCrowdStrike$1.4B in FY202628.8%
- 10METAMeta Platforms$57.4B in FY202528.5%
Cash and short-term investments beyond every dollar of debt: the cushion that lets a business ignore a bad year.
Piotroski F-Score: profitable, cash-backed, less leveraged, more liquid, no dilution, better margins and turnover than a year before.
- 2STESTERIS plc$22.1B market value9 of 9
- 3PTCPTC Inc.$21.2B market value9 of 9
- 4WWDWoodward, Inc.$18.0B market value9 of 9
- 5BSYBentley Systems, Incorporated$12.4B market value9 of 9
- 6HQYHealthEquity, Inc.$8.5B market value9 of 9
- 7AWIArmstrong World Industries, Inc.$7.0B market value9 of 9
- 8OTEXOpen Text Corporation$6.4B market value9 of 9
- 9FTDRFrontdoor, Inc.$6.0B market value9 of 9
- 10CHEFThe Chefs' Warehouse, Inc.$4.3B market value9 of 9
The longest cash conversion cycles: money spent on stock and on credit to customers long before it comes back.
- 2MGNIMagnite, Inc.inventory 0 days, receivables 666645 days
- 3SUPNSupernus Pharmaceuticals, Inc.inventory 551 days, receivables 95633 days
- 4BF-ABrown-Forman Corporationinventory 599 days, receivables 77626 days
- 5OLEDUniversal Display Corporationinventory 571 days, receivables 67583 days
- 6IBRXImmunityBio, Inc.inventory 441 days, receivables 137578 days
- 7TVTXTravere Therapeutics, Inc.inventory 1276 days, receivables 60461 days
- 8ACADACADIA Pharmaceuticals Inc.inventory 457 days, receivables 41453 days
- 9AXTIAXT, Inc.inventory 387 days, receivables 111436 days
- 10ADMAADMA Biologics, Inc.inventory 347 days, receivables 113422 days
Each figure is the one its company page draws: return on capital and net cash from the latest statements, buybacks and stock pay from the latest annual report, the cash conversion cycle from the latest fiscal year’s receivables, inventory and payables, the Piotroski F-Score from the two latest 10-Ks. More ready-made lists live under Screens.